0001169245-20-000016.txt : 20200214 0001169245-20-000016.hdr.sgml : 20200214 20200214183859 ACCESSION NUMBER: 0001169245-20-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burkhardt Glen CENTRAL INDEX KEY: 0001803271 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 20622538 MAIL ADDRESS: STREET 1: C/O PHASEBIO PHARMACEUTICALS, INC. STREET 2: 1 GREAT VALLEY PKWY.,SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4 1 wf-form4_158172352213967.xml FORM 4 X0306 4 2020-02-12 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001803271 Burkhardt Glen C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355 0 1 0 0 VP, Human Resources Employee Stock Option (right to buy) 5.19 2020-02-12 4 A 0 55000 0 A 2030-02-12 Common Stock 55000.0 55000 D Employee Stock Option (right to buy) 5.19 2020-02-12 4 A 0 20000 0 A 2030-02-12 Common Stock 20000.0 20000 D The shares subject to the option shall vest in equal monthly installments over 48 months from February 12, 2020, subject to the reporting person's continued service through each such date. One-fourth (1/4th) of the shares vest one year after the initial vesting date of March 15, 2019; the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the first anniversary of the initial vesting date, subject to the Reporting Person's continuous service as of each such date. /s/ John Sharp, Attorney-in-fact 2020-02-14